查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1330907

神經血管設備/介入神經設備的全球市場

Neurovascular Devices / Interventional Neurology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球神經血管/介入神經設備市場將達到 54 億美元

在COVID-19之後的商業環境發生變化的情況下，全球神經血管/介入神經設備市場預計2022年為31億美元，預計到2030年將達到54億美元，預計到2030年將以7.3%的年複合成長率成長。動脈瘤彈簧圈和栓塞設備是本報告分析的細分市場之一，預計年複合成長率8.2%，到分析期結束時將達到 25 億美元。鑑於大流行後的持續復甦，未來八年神經血栓切除術設備領域的年複合成長率年成長率已調整為 6.5%。

美國市場預計將成長9.341億美元，中國年複合成長率為6.9%

到 2022 年，美國神經血管/介入神經設備市場預計將達到 9.341 億美元。中國作為世界第二大經濟體，預計到2030年市場規模將達到9.386億美元，2022年至2030年的分析期間年複合成長率為6.9%。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 6.8% 和 5.8%。在歐洲，德國預計年複合成長率約為 5.8%。

受訪企業示例

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates, Inc.

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP13584

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Neurovascular Devices / Interventional Neurology Market to Reach $5.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Neurovascular Devices / Interventional Neurology estimated at US$3.1 Billion in the year 2022, is projected to reach a revised size of US$5.4 Billion by 2030, growing at aCAGR of 7.3% over the period 2022-2030. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$2.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Neurothrombectomy Devices segment is readjusted to a revised 6.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $934.1 Million, While China is Forecast to Grow at 6.9% CAGR

The Neurovascular Devices / Interventional Neurology market in the U.S. is estimated at US$934.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$938.6 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 5.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W.L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Neurovascular Devices/Interventional Neurology - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Ischemic Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Ischemic Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Ischemic Strokes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cerebral Aneurysms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cerebral Aneurysms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cerebral Aneurysms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Neurovascular Devices / Interventional Neurology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurovascular Devices / Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 10: World 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Aneurysm Coiling & Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Aneurysm Coiling & Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 13: World 16-Year Perspective for Aneurysm Coiling & Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurothrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurothrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neurothrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Arteriovenous Malformation & Fistulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Arteriovenous Malformation & Fistulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Arteriovenous Malformation & Fistulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Disease Pathologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Disease Pathologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Disease Pathologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: China 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: France 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: France 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2014, 2023 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2014, 2023 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION